Literature DB >> 12352461

Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines.

Vasundara Venkateswaran1, Neil E Fleshner, Laurence H Klotz.   

Abstract

PURPOSE: Vitamin E has been identified as a candidate agent for the prevention of prostate cancer. We hypothesize that the mechanism for this effect is in part a result of cell cycle inhibition rather than only due to a reduction in reactive oxygen species. We tested whether vitamin E induces cell cycle arrest in prostate carcinoma, mediated by alterations in cell cycle regulatory proteins, including cyclin E, cdk2 and p27.
MATERIALS AND METHODS: Cells were incubated with and without vitamin E (alpha-tocopherol succinate, 20 microg./ml.), fixed and stained with propidium iodide for flow cytometry analysis. In parallel experiments total protein was extracted, immunoprecipitated with cyclin E antibody and analyzed by Western blot for the expression of cell cycle markers.
RESULTS: Flow cytometry analysis revealed a dramatic reduction in the S phase percent of LNCaP and PC3 cells in response to vitamin E (69% and 95%, respectively). It was accompanied by over expression of p27 (3-fold increase) with vitamin E treatment.
CONCLUSIONS: This study demonstrates that at physiological concentrations vitamin E induced profound cell cycle arrest mediated by up-regulation of p27. This observation provides a theoretical basis for the putative chemopreventive effect of vitamin E.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12352461     DOI: 10.1097/01.ju.0000030156.80151.bb

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  15 in total

Review 1.  Diet and prostate cancer: mechanisms of action and implications for chemoprevention.

Authors:  Vasundara Venkateswaran; Laurence H Klotz
Journal:  Nat Rev Urol       Date:  2010-07-20       Impact factor: 14.432

Review 2.  Complementary and alternative medicines in prostate cancer: from bench to bedside?

Authors:  Samuel J Klempner; Glenn Bubley
Journal:  Oncologist       Date:  2012-05-22

3.  A Phase II Randomized Trial of Lycopene-Rich Tomato Extract Among Men with High-Grade Prostatic Intraepithelial Neoplasia.

Authors:  Peter H Gann; Ryan J Deaton; Erika Enk Rueter; Richard B van Breemen; Larisa Nonn; Virgilia Macias; Misop Han; Viju Ananthanarayanan
Journal:  Nutr Cancer       Date:  2015       Impact factor: 2.900

Review 4.  Advanced prostate cancer--a case for adjuvant differentiation therapy.

Authors:  Jayant K Rane; Davide Pellacani; Norman J Maitland
Journal:  Nat Rev Urol       Date:  2012-08-14       Impact factor: 14.432

5.  Micronutrients attenuate progression of prostate cancer by elevating the endogenous inhibitor of angiogenesis, platelet factor-4.

Authors:  David Cervi; Brian Pak; Natalie A Venier; Linda M Sugar; Robert K Nam; Neil E Fleshner; Laurence H Klotz; Vasundara Venkateswaran
Journal:  BMC Cancer       Date:  2010-06-04       Impact factor: 4.430

6.  Associations between alpha-tocopherol, beta-carotene, and retinol and prostate cancer survival.

Authors:  Joanne L Watters; Mitchell H Gail; Stephanie J Weinstein; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Res       Date:  2009-04-21       Impact factor: 12.701

7.  Novel transcriptional activities of vitamin E: inhibition of cholesterol biosynthesis.

Authors:  Scott Valastyan; Varsha Thakur; Amy Johnson; Karan Kumar; Danny Manor
Journal:  Biochemistry       Date:  2007-12-21       Impact factor: 3.162

Review 8.  Vitamin E: a dark horse at the crossroad of cancer management.

Authors:  Eduardo Cardenas; Rita Ghosh
Journal:  Biochem Pharmacol       Date:  2013-08-03       Impact factor: 5.858

Review 9.  What's new in the field of prostate cancer chemoprevention?

Authors:  Kanwaljit Mahal; Javier Hernandez; Joseph W Basler; Ian M Thompson
Journal:  Curr Oncol Rep       Date:  2004-05       Impact factor: 5.075

10.  Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Authors:  Scott M Lippman; Eric A Klein; Phyllis J Goodman; M Scott Lucia; Ian M Thompson; Leslie G Ford; Howard L Parnes; Lori M Minasian; J Michael Gaziano; Jo Ann Hartline; J Kellogg Parsons; James D Bearden; E David Crawford; Gary E Goodman; Jaime Claudio; Eric Winquist; Elise D Cook; Daniel D Karp; Philip Walther; Michael M Lieber; Alan R Kristal; Amy K Darke; Kathryn B Arnold; Patricia A Ganz; Regina M Santella; Demetrius Albanes; Philip R Taylor; Jeffrey L Probstfield; T J Jagpal; John J Crowley; Frank L Meyskens; Laurence H Baker; Charles A Coltman
Journal:  JAMA       Date:  2008-12-09       Impact factor: 56.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.